Code intelligence

C91.00 reimbursement alerts

Policy changes, MAC LCD updates, and CMS guidance matched to code C91.00.

Critical code riskView ICD-10 detail

Signal breakdown

4 shown · 4 total in platform

Risk: Critical

Critical

25%

High

25%

Routine

50%

Low

New this month

alerts added in last 30 days

Effective soon

—

no upcoming deadlines

Proposed LCD DL40407: MolDX: Genome-Wide Molecular Methodologies for the Detection of Copy Number Alterations and Structural Variants in Hematologic Neoplasms — Palmetto GBA

Policy LCD-DL40407 · Oncology

Critical

Proposed LCD: Genome-wide CNA/SV testing in blood cancers—comment by 10/11/26

View alert

LCD L40226: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Targeted Therapy in Cancer — CGS

Policy LCD-L40226 · Oncology

High

CGS final LCD sets NGS-alternative molecular panel rules for cancer therapy

View alert

LCD L38125: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies — Noridian

Policy LCD-L38125 · Oncology

Routine

New LCD for myeloid malignancies requires billing team review.

View alert

LCD L36094: Lab: Flow Cytometry — Noridian

Policy LCD-L36094 · Clinical Laboratory

Routine

New LCD for Flow Cytometry affects lab billing practices.

View alert

Audit documentation

Building an audit file that includes C91.00?

The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.

Get the Oncology audit pack — $349One-time purchase · not a subscription